PTEN and colorectal carcinoma: Promoting PTEN expression in CRC cell lines will stop the activation of the phosphatidylinositol-3-kinase (PI3K)/sinkserine/threonine kinase (Akt) signaling pathway, which affects CRC cell growth, promotes apoptosis, and improves sensitivity to targeted therapy, immunotherapy, and conventional therapy.